Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Inflammatory Bowel Diseases

Free Subscription 19.12.2011 10 Aliment Pharmacol Ther 2 Am J Gastroenterol 1 BMJ 2 Can J Gastroenterol 1 Clin Exp Immunol 4 Clin Res Hepatol Gastroenterol 2 Dig Dis 3 Dis Colon Rectum 3 Eur J Gastroenterol Hepatol 1 Gastroenterol Hepatol 4 Gastroenterology 1 Gut 3 Inflamm Bowel Dis 2 J Clin Gastroenterol 1 Scand J Gastroenterol

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Aliment Pharmacol Ther

1. BACCHIERI A , Camerini R
   Is propionyl-L-carnitine therapy effective in ulcerative colitis? authors' reply.
   Aliment Pharmacol Ther. 2012;35:316-7.
   PubMed     Text format     Related articles   
   
   
   
2. TURNER LV , Hamlin PJ
   Is propionyl-l-carnitine therapy effective in ulcerative colitis?
   Aliment Pharmacol Ther. 2012;35:315-6.
   PubMed     Text format     Related articles   
   
   
   
3. OLIVA S , Di Nardo G, Ferrari F, Mallardo S, et al
   Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis.
   Aliment Pharmacol Ther. 2011 Dec 8. doi: 10.1111/j.1365-2036.2011.04939.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. BROOKS AJ , Lobo AJ
   Are mesalazine granules superior to Eudragit-L-coated mesalazine tablets for induction of remission in distal ulcerative colitis?
   Aliment Pharmacol Ther. 2012;35:193-4.
   PubMed     Text format     Related articles   
   
   
   
5. TERRY A , Grogan JL, Casson DH, Dalzell AM, et al
   Tube feeding therapy in paediatric Crohn's disease.
   Aliment Pharmacol Ther. 2011;34:260-1.
   PubMed     Text format     Related articles   
   
   
   
6. BAGEACU S , Coatmeur O, Lemaitre JP, Lointier P, et al
   Appendicectomy as a potential therapy for refractory ulcerative proctitis.
   Aliment Pharmacol Ther. 2011;34:257-8.
   PubMed     Text format     Related articles   
   
   
   
7. PANES J , Bouzas R, Chaparro M, Garcia-Sanchez V, et al
   Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease.
   Aliment Pharmacol Ther. 2011;34:125-45.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. LEE TW , Singh R, Fedorak RN
   A one-hour infusion of infliximab during maintenance therapy is safe and well tolerated: a prospective cohort study.
   Aliment Pharmacol Ther. 2011;34:181-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. CHOURAKI V , Savoye G, Dauchet L, Vernier-Massouille G, et al
   The changing pattern of Crohn's disease incidence in northern France: a continuing increase in the 10- to 19-year-old age bracket (1988-2007).
   Aliment Pharmacol Ther. 2011;33:1133-42.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. FEAGAN BG , Hanauer SB, Coteur G, Schreiber S, et al
    Evaluation of a daily practice composite score for the assessment of Crohn's disease: the treatment impact of certolizumab pegol.
    Aliment Pharmacol Ther. 2011;33:1143-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Am J Gastroenterol

11. CAPPELLO M , Bravata I, Cocorullo G, Cacciatore M, et al
    Splenic littoral cell hemangioendothelioma in a patient with Crohn's disease previously treated with immunomodulators and anti-TNF agents: a rare tumor linked to deep immunosuppression.
    Am J Gastroenterol. 2011;106:1863-5.
    PubMed     Text format     Related articles   
    
    
    
12. AKOBENG AK
    Efficacy of 5-aminosalicylates for the maintenance of remission in Crohn's disease.
    Am J Gastroenterol. 2011;106:1857.
    PubMed     Text format     Related articles   
    
    
    

    
    BMJ

13. BARDAGE C , Persson I, Ortqvist A, Bergman U, et al
    Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden.
    BMJ. 2011;343:d5956.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Can J Gastroenterol

14. LOOMES DE , Teshima C, Jacobs P, Fedorak RN, et al
    Health care resource use and costs in Crohn's disease before and after infliximab therapy.
    Can J Gastroenterol. 2011;25:497-502.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. BINION DG , Louis E, Oldenburg B, Mulani P, et al
    Effect of adalimumab on work productivity and indirect costs in moderate to severe Crohn's disease: a meta-analysis.
    Can J Gastroenterol. 2011;25:492-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Clin Exp Immunol

16. MITSUYAMA K , Niwa M, Masuda J, Kuwaki K, et al
    Isolation and characterization of a novel short peptide associated with Crohn's disease.
    Clin Exp Immunol. 2011;166:72-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Clin Res Hepatol Gastroenterol

17. EUGENE C
    Ulcerative colitis practice guidelines in adults.
    Clin Res Hepatol Gastroenterol. 2011.
    PubMed     Text format     Related articles   
    
    
    
18. MACAIGNE G , Harnois F, Boivin JF, Dikov D, et al
    Crohn's disease revealed by a cheilitis granulomatosa with favorable evolution by perfusions of infliximab: report of a case and review of the literature.
    Clin Res Hepatol Gastroenterol. 2011;35:147-9.
    PubMed     Text format     Related articles   
    
    
    
19. O'NEILL SB , O'Connor OJ, McWilliams SR, Shanahan F, et al
    Minimization of radiation exposure due to computed tomography in inflammatory bowel disease.
    Clin Res Hepatol Gastroenterol. 2011;35:105-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. LESAGE AC , Hagege H, Tucat G, Gendre JP, et al
    Results of a national survey on quality of life in inflammatory bowel diseases.
    Clin Res Hepatol Gastroenterol. 2011;35:117-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Dig Dis

21. GOETZ M
    Colonoscopic surveillance in inflammatory bowel disease: state of the art reduction of biopsies.
    Dig Dis. 2011;29 Suppl 1:36-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. BAUMGART DC
    Endoscopic surveillance in Crohn's disease and ulcerative colitis: who needs what and when?
    Dig Dis. 2011;29 Suppl 1:32-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Dis Colon Rectum

23. LIAN L , Menon KV, Shen B, Remzi F, et al
    Inflammatory bowel disease complicated by primary sclerosing cholangitis and cirrhosis: is restorative proctocolectomy safe?
    Dis Colon Rectum. 2012;55:79-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. LINDSTROM L , Lapidus A, Ost A, Bergquist A, et al
    Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis.
    Dis Colon Rectum. 2011;54:1392-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. O'RIORDAN JM , O'Connor BI, Huang H, Victor JC, et al
    Long-term outcome of colectomy and ileorectal anastomosis for Crohn's colitis.
    Dis Colon Rectum. 2011;54:1347-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Eur J Gastroenterol Hepatol

26. ALBUQUERQUE A , Magro F, Rodrigues S, Lopes J, et al
    Metastatic cutaneous Crohn's disease of the face: a case report and review of the literature.
    Eur J Gastroenterol Hepatol. 2011;23:954-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. BRUHL J , Schirren M, Wei C, Antoni C, et al
    Prospective noninvasive analysis of hepatic fibrosis in patients with Crohn's disease: correlation of transient elastography and laboratory-based markers.
    Eur J Gastroenterol Hepatol. 2011;23:923-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. SINGEAP AM , Trifan A, Cojocariu C, Sfarti C, et al
    Outcomes after symptomatic capsule retention in suspected small bowel obstruction.
    Eur J Gastroenterol Hepatol. 2011;23:886-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Gastroenterol Hepatol

29. CABRIADA JL
    [Apheresis in inflammatory bowel disease. a valid option?]
    Gastroenterol Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Gastroenterology

30. NASR JY , Lloyd J, Yadav D
    An unusual cause of fibrostenotic terminal ileal disease.
    Gastroenterology. 2011;141:e5-6.
    PubMed     Text format     Related articles   
    
    
    
31. STIDHAM RW , Xu J, Johnson LA, Kim K, et al
    Ultrasound elasticity imaging for detecting intestinal fibrosis and inflammation in rats and humans with Crohn's disease.
    Gastroenterology. 2011;141:819-826.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. CHOI K , Chen J, Mitra S, Sarna SK, et al
    Impaired integrity of DNA after recovery from inflammation causes persistent dysfunction of colonic smooth muscle.
    Gastroenterology. 2011;141:1293-1301.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. NIMMO ER , Stevens C, Phillips AM, Smith A, et al
    TLE1 modifies the effects of NOD2 in the pathogenesis of Crohn's disease.
    Gastroenterology. 2011;141:972-981.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Gut

34. BEAUGERIE L
    Inflammatory bowel disease therapies and cancer risk: where are we and where are we going?
    Gut. 2011.
    PubMed     Text format     Related articles   
    
    
    

    
    Inflamm Bowel Dis

35. MICHAIL S , Durbin M, Turner D, Griffiths AM, et al
    Alterations in the gut microbiome of children with severe ulcerative colitis.
    Inflamm Bowel Dis. 2011 Dec 14. doi: 10.1002/ibd.22860.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. TORRES J , Billioud V, Sachar DB, Peyrin-Biroulet L, et al
    Ulcerative colitis as a progressive disease: The forgotten evidence.
    Inflamm Bowel Dis. 2011 Dec 11. doi: 10.1002/ibd.22839.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. 
    Abstracts of the 2011 Advances in Inflammatory Bowel Diseases Crohn's & Colitis Foundation's National Clinical & Research Conference. December 1-3, 2011. Hollywood, Florida, USA.
    Inflamm Bowel Dis. 2011;17 Suppl 2:S1-99.
    PubMed     Text format     Related articles   
    
    
    

    
    J Clin Gastroenterol

38. CHANDE N , Abdelgadir I, Gregor J
    The safety and tolerability of methotrexate for treating patients with Crohn's disease.
    J Clin Gastroenterol. 2011;45:599-601.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. SLATTERY E , Keegan D, Hyland J, O'donoghue D, et al
    Surgery, Crohn's disease, and the biological era: has there been an impact?
    J Clin Gastroenterol. 2011;45:691-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Scand J Gastroenterol

40. PETERSEN AM , Schou C, Mirsepasi H, Engberg J, et al
    Seroreactivity to E. coli outer membrane protein C antibodies in active inflammatory bowel disease; diagnostic value and correlation with phylogroup B2 E. coli infection.
    Scand J Gastroenterol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: